Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Association of dopamine agonist use with impulse control disorders in Parkinson disease.
|
Arch Neurol
|
2006
|
3.02
|
2
|
Facial emotion perception in schizophrenia: a meta-analytic review.
|
Schizophr Bull
|
2009
|
2.98
|
3
|
An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signaling in schizophrenia.
|
Am J Psychiatry
|
2008
|
2.53
|
4
|
Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.
|
Mov Disord
|
2014
|
2.30
|
5
|
Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging.
|
Alzheimers Dement
|
2012
|
2.13
|
6
|
Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
|
J Am Geriatr Soc
|
2004
|
2.00
|
7
|
Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.
|
J Am Geriatr Soc
|
2008
|
1.92
|
8
|
Recognition and treatment of depression in Parkinson's disease.
|
J Geriatr Psychiatry Neurol
|
2003
|
1.71
|
9
|
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease.
|
Mov Disord
|
2011
|
1.57
|
10
|
The Penn Conditional Exclusion Test: a new measure of executive-function with alternate forms of repeat administration.
|
Arch Clin Neuropsychol
|
2004
|
1.57
|
11
|
Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores.
|
Parkinsonism Relat Disord
|
2008
|
1.49
|
12
|
Evidence for impaired encoding and retrieval memory profiles in Parkinson disease.
|
Cogn Behav Neurol
|
2004
|
1.34
|
13
|
Antidepressant studies in Parkinson's disease: a review and meta-analysis.
|
Mov Disord
|
2005
|
1.32
|
14
|
Neuropsychological deficits among patients with late-onset minor and major depression.
|
Arch Clin Neuropsychol
|
2003
|
1.30
|
15
|
Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness.
|
Arch Neurol
|
2010
|
1.29
|
16
|
Facial emotion perception in depression and bipolar disorder: a quantitative review.
|
Psychiatry Res
|
2011
|
1.27
|
17
|
Neurodegeneration across stages of cognitive decline in Parkinson disease.
|
Arch Neurol
|
2011
|
1.26
|
18
|
Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease.
|
Ann Neurol
|
2010
|
1.20
|
19
|
Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
|
J Nucl Med
|
2005
|
1.15
|
20
|
Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study.
|
Schizophr Bull
|
2005
|
1.13
|
21
|
Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia.
|
Arch Gen Psychiatry
|
2003
|
1.09
|
22
|
Scents and nonsense: olfactory dysfunction in schizophrenia.
|
Schizophr Bull
|
2009
|
1.08
|
23
|
Memory-delineated subtypes of schizophrenia: relationship to clinical, neuroanatomical, and neurophysiological measures.
|
Neuropsychology
|
2002
|
1.04
|
24
|
Low olfactory bulb volume in first-degree relatives of patients with schizophrenia.
|
Am J Psychiatry
|
2003
|
1.03
|
25
|
Physiologic impairment of olfactory stimulus processing in schizophrenia.
|
Biol Psychiatry
|
2003
|
1.03
|
26
|
Dimensions of executive function in Parkinson's disease.
|
Dement Geriatr Cogn Disord
|
2005
|
0.97
|
27
|
Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis.
|
World J Biol Psychiatry
|
2011
|
0.96
|
28
|
Unirhinal olfactory function in schizophrenia patients and first-degree relatives.
|
J Neuropsychiatry Clin Neurosci
|
2006
|
0.95
|
29
|
Computerized neurocognitive test performance in schizophrenia: a lifespan analysis.
|
Am J Geriatr Psychiatry
|
2012
|
0.95
|
30
|
Neuropsychological performance in older patients with schizophrenia: a meta-analysis of cross-sectional and longitudinal studies.
|
Schizophr Bull
|
2010
|
0.94
|
31
|
Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life.
|
J Neurosurg
|
2007
|
0.93
|
32
|
Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease.
|
Parkinsonism Relat Disord
|
2006
|
0.90
|
33
|
Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease.
|
Schizophr Res
|
2002
|
0.89
|
34
|
Normative data for the symbol cancellation test in young healthy adults.
|
Appl Neuropsychol
|
2004
|
0.88
|
35
|
Olfactory receptor neuron dysfunction in schizophrenia.
|
Neuropsychopharmacology
|
2008
|
0.87
|
36
|
Identification of pleasant, neutral, and unpleasant odors in schizophrenia.
|
Psychiatry Res
|
2011
|
0.87
|
37
|
Medication management and neuropsychological performance in Parkinson's disease.
|
Clin Neuropsychol
|
2011
|
0.86
|
38
|
Reduced posterior nasal cavity volume: a gender-specific neurodevelopmental abnormality in schizophrenia.
|
Schizophr Res
|
2007
|
0.86
|
39
|
Olfactory physiological impairment in first-degree relatives of schizophrenia patients.
|
Schizophr Res
|
2008
|
0.85
|
40
|
Assessing the executive function deficits of patients with Parkinson's disease: utility of the Tower of London-Drexel.
|
Assessment
|
2004
|
0.83
|
41
|
The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults.
|
Bipolar Disord
|
2010
|
0.83
|
42
|
Olfaction and schizophrenia clinical risk status: just the facts.
|
Schizophr Res
|
2012
|
0.83
|
43
|
Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients.
|
Schizophr Bull
|
2011
|
0.83
|
44
|
The TCN/AACN 2010 "salary survey": professional practices, beliefs, and incomes of U.S. neuropsychologists.
|
Clin Neuropsychol
|
2011
|
0.82
|
45
|
Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine.
|
Neuropsychopharmacology
|
2004
|
0.81
|
46
|
Verbal learning and memory in older adults with minor and major depression.
|
Arch Clin Neuropsychol
|
2011
|
0.81
|
47
|
Relationship between clock-drawing and neuropsychological and functional status in elderly institutionalized patients with schizophrenia.
|
Am J Geriatr Psychiatry
|
2003
|
0.80
|
48
|
The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth.
|
J Psychiatr Res
|
2013
|
0.80
|
49
|
Depth of the olfactory sulcus: a marker of early embryonic disruption in schizophrenia?
|
Schizophr Res
|
2009
|
0.79
|
50
|
The TCN/AACN 2005 "salary survey": professional practices, beliefs, and incomes of U.S. neuropsychologists.
|
Clin Neuropsychol
|
2006
|
0.78
|
51
|
Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults.
|
Aging Ment Health
|
2013
|
0.78
|
52
|
Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia.
|
Behav Neurosci
|
2011
|
0.77
|
53
|
Association between facial emotion recognition and odor identification in schizophrenia.
|
J Neuropsychiatry Clin Neurosci
|
2007
|
0.77
|
54
|
Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: testing the evidence for an endophenotypic marker.
|
Psychiatry Res
|
2012
|
0.76
|
55
|
An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis.
|
Schizophr Res
|
2012
|
0.75
|
56
|
The influence of semantic processing on odor identification ability in schizophrenia.
|
Arch Clin Neuropsychol
|
2013
|
0.75
|